BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 14677678)

  • 1. Vaccines and foot-and-mouth disease eradication in South America.
    Saraiva V
    Dev Biol (Basel); 2003; 114():67-77. PubMed ID: 14677678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of vaccines in South American foot-and-mouth disease eradication programmes.
    Saraiva V; Darsie G
    Dev Biol (Basel); 2004; 119():33-40. PubMed ID: 15742616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of foot and mouth disease: the experience of the Americas.
    Correa Melo E; López A
    Rev Sci Tech; 2002 Dec; 21(3):695-8, 689-94. PubMed ID: 12523707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foot-and-mouth disease in the Americas: epidemiology and ecologic changes affecting distribution.
    Saraiva V
    Ann N Y Acad Sci; 2004 Oct; 1026():73-8. PubMed ID: 15604472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving perception on the benefits of vaccination as a foot and mouth disease control policy: contributions of South America.
    Bergmann IE; Malirat V; Falczuk AJ
    Expert Rev Vaccines; 2005 Dec; 4(6):903-13. PubMed ID: 16372885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-capsid proteins to identify foot-and-mouth disease viral circulation in cattle irrespective of vaccination.
    Bergmann IE; Malirat V; Neitzert E
    Biologicals; 2005 Dec; 33(4):235-9. PubMed ID: 16257539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International approach to eradication and surveillance for foot-and-mouth disease in the Americas.
    Rodriguez-Torres JG
    Ann N Y Acad Sci; 2000; 916():194-8. PubMed ID: 11193621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review of the status of foot and mouth disease in countries of South America and approaches to control and eradication.
    Correa Melo E; Saraiva V; Astudillo V
    Rev Sci Tech; 2002 Dec; 21(3):429-36. PubMed ID: 12523684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of vaccines toward the global control and eradication of foot-and-mouth disease.
    Rodriguez LL; Gay CG
    Expert Rev Vaccines; 2011 Mar; 10(3):377-87. PubMed ID: 21434805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination: foot-and-mouth disease experience in South America.
    Bergmann IE; Malirat V; Neitzert E; Correa Melo E
    Dev Biol (Basel); 2004; 119():273-82. PubMed ID: 15742639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.
    Mattion N; König G; Seki C; Smitsaart E; Maradei E; Robiolo B; Duffy S; León E; Piccone M; Sadir A; Bottini R; Cosentino B; Falczuk A; Maresca R; Periolo O; Bellinzoni R; Espinoza A; Torre JL; Palma EL
    Vaccine; 2004 Oct; 22(31-32):4149-62. PubMed ID: 15474705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines and companion diagnostic tests for foot-and-mouth disease virus. An overview of the experience in South America.
    Bergmann IE; Malirat V; Neitzert E; Correa Melo E
    Dev Biol (Basel); 2003; 114():59-65. PubMed ID: 14677677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategy for the control of foot-and-mouth disease in Uruguay.
    Ugarte R
    Dev Biol (Basel); 2004; 119():415-21. PubMed ID: 15742654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk evaluation of nonvaccinated, weaned calves transported through areas under systematic foot and mouth disease (FMD) vaccination.
    Leanes LF; Abbiati NN; Pereyra AM; Maizon DO
    Prev Vet Med; 2011 Feb; 98(2-3):133-41. PubMed ID: 21071104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global perspective for foot and mouth disease control.
    Rweyemamu MM; Astudillo VM
    Rev Sci Tech; 2002 Dec; 21(3):765-73. PubMed ID: 12523713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
    Lombard M; Füssel AE
    Rev Sci Tech; 2007 Apr; 26(1):117-34. PubMed ID: 17633297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk of transmission of foot and mouth disease by milk and its products: perspectives in South America].
    Muzio FJ; Días LE; Blanco ML
    Rev Sci Tech; 1997 Apr; 16(1):125-34. PubMed ID: 9537741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foot and mouth disease virus vaccines.
    Rodriguez LL; Grubman MJ
    Vaccine; 2009 Nov; 27 Suppl 4():D90-4. PubMed ID: 19837296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.